XTL Biopharmaceuticals Ltd.

Regulatory Filings • Feb 17, 2015

_________ false

C003��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: -11996381Medinat hayehudim st 85 , Herzliya 4614001 , ,Tel: 09-9557080 , Fax: 09-9519727E.mail address: ir@xtlbio.comReported via MAGNA: 17/02/2015              Time of broadcast: 18:10 18:09:31

Company site:		www.xtlbio.com

Reference: 2015-02-033514

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Alex Rabinovich increased his stake in the Company through his investment in InterCure

XTL_170215_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 12/01/2015
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Legal Adviser , Name of Employer Company: .
Abba Hillel Silver Rd Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2